However, the transient nature of CRS and the number of CYP enzymes likely affected by elevated cytokines indeed make it difficult to design and conduct dedicated clinical studies to address CRS‐mediated drug interactions. This evidence concerns the gene PPIG and congenital rubella syndrome.